These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

487 related items for PubMed ID: 28257307

  • 1. Small intestinal bacterial overgrowth as a cause for irritable bowel syndrome: guilty or not guilty?
    Aziz I, Törnblom H, Simrén M.
    Curr Opin Gastroenterol; 2017 May; 33(3):196-202. PubMed ID: 28257307
    [Abstract] [Full Text] [Related]

  • 2. [Clinical features of irritable bowel syndrome with small intestinal bacterial overgrowth and a preliminary study of effectiveness of Rifaximin].
    Liu ZJ, Wei H, Duan LP, Zhu SW, Zhang L, Wang K.
    Zhonghua Yi Xue Za Zhi; 2016 Jun 28; 96(24):1896-902. PubMed ID: 27373356
    [Abstract] [Full Text] [Related]

  • 3. Small intestinal bacterial overgrowth is associated to symptoms in irritable bowel syndrome. Evidence from a multicentre study in Romania.
    Moraru IG, Moraru AG, Andrei M, Iordache T, Drug V, Diculescu M, Portincasa P, Dumitrascu DL.
    Rom J Intern Med; 2014 Jun 28; 52(3):143-50. PubMed ID: 25509557
    [Abstract] [Full Text] [Related]

  • 4. Small intestinal bacterial overgrowth produces symptoms in irritable bowel syndrome which are improved by rifaximin. A pilot study.
    Moraru IG, Portincasa P, Moraru AG, Diculescu M, Dumitraşcu DL.
    Rom J Intern Med; 2013 Jun 28; 51(3-4):143-7. PubMed ID: 24620626
    [Abstract] [Full Text] [Related]

  • 5. Small intestine bacterial overgrowth in irritable bowel syndrome: a retrospective study with rifaximin.
    Cuoco L, Salvagnini M.
    Minerva Gastroenterol Dietol; 2006 Mar 28; 52(1):89-95. PubMed ID: 16554709
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Short-course Rifaximin therapy efficacy and lactulose hydrogen breath test in Chinese patients with diarrhea-predominant irritable bowel syndrome.
    Zhuang X, Tian Z, Luo M, Xiong L.
    BMC Gastroenterol; 2020 Jun 12; 20(1):187. PubMed ID: 32532214
    [Abstract] [Full Text] [Related]

  • 9. Chronic prostatitis and small intestinal bacterial overgrowth: effect of rifaximin.
    Weinstock LB, Geng B, Brandes SB.
    Can J Urol; 2011 Aug 12; 18(4):5826-30. PubMed ID: 21854715
    [Abstract] [Full Text] [Related]

  • 10. A meta-analysis on small intestinal bacterial overgrowth in patients with different subtypes of irritable bowel syndrome.
    Ghoshal UC, Nehra A, Mathur A, Rai S.
    J Gastroenterol Hepatol; 2020 Jun 12; 35(6):922-931. PubMed ID: 31750966
    [Abstract] [Full Text] [Related]

  • 11. Rifaximin treatment for small intestinal bacterial overgrowth in children with irritable bowel syndrome.
    Scarpellini E, Giorgio V, Gabrielli M, Filoni S, Vitale G, Tortora A, Ojetti V, Gigante G, Fundarò C, Gasbarrini A.
    Eur Rev Med Pharmacol Sci; 2013 May 12; 17(10):1314-20. PubMed ID: 23740443
    [Abstract] [Full Text] [Related]

  • 12. Review article: potential mechanisms of action of rifaximin in the management of irritable bowel syndrome with diarrhoea.
    Pimentel M.
    Aliment Pharmacol Ther; 2016 Jan 12; 43 Suppl 1():37-49. PubMed ID: 26618924
    [Abstract] [Full Text] [Related]

  • 13. Breath tests in the diagnosis of small intestinal bacterial overgrowth in patients with irritable bowel syndrome in comparison with quantitative upper gut aspirate culture.
    Ghoshal UC, Srivastava D, Ghoshal U, Misra A.
    Eur J Gastroenterol Hepatol; 2014 Jul 12; 26(7):753-60. PubMed ID: 24849768
    [Abstract] [Full Text] [Related]

  • 14. Microscopic colitis and small intestinal bacterial overgrowth--diagnosis behind the irritable bowel syndrome?
    Stoicescu A, Andrei M, Becheanu G, Stoicescu M, Nicolaie T, Diculescu M.
    Rev Med Chir Soc Med Nat Iasi; 2012 Jul 12; 116(3):766-72. PubMed ID: 23272525
    [Abstract] [Full Text] [Related]

  • 15. Increased incidence of small intestinal bacterial overgrowth during proton pump inhibitor therapy.
    Lombardo L, Foti M, Ruggia O, Chiecchio A.
    Clin Gastroenterol Hepatol; 2010 Jun 12; 8(6):504-8. PubMed ID: 20060064
    [Abstract] [Full Text] [Related]

  • 16. [Estimation of small intestinal bacterial overgrowth in patients with constipation and diarrhea irritable bowel syndrome].
    Łokieć K, Klupińska G, Walecka-Kapica E, Błońska A.
    Pol Merkur Lekarski; 2014 May 12; 36(215):307-10. PubMed ID: 24964506
    [Abstract] [Full Text] [Related]

  • 17. Small intestine bacterial overgrowth and irritable bowel syndrome-related symptoms: experience with Rifaximin.
    Peralta S, Cottone C, Doveri T, Almasio PL, Craxi A.
    World J Gastroenterol; 2009 Jun 07; 15(21):2628-31. PubMed ID: 19496193
    [Abstract] [Full Text] [Related]

  • 18. Critical appraisal of the SIBO hypothesis and breath testing: A clinical practice update endorsed by the European society of neurogastroenterology and motility (ESNM) and the American neurogastroenterology and motility society (ANMS).
    Kashyap P, Moayyedi P, Quigley EMM, Simren M, Vanner S.
    Neurogastroenterol Motil; 2024 Jun 07; 36(6):e14817. PubMed ID: 38798120
    [Abstract] [Full Text] [Related]

  • 19. Total Bilirubin Is Associated with Small Intestinal Bacterial Overgrowth in Diarrhea Predominant Irritable Bowel Syndrome.
    Kim SY, Seo YS, Lee ES, Kim KN.
    Ann Clin Lab Sci; 2019 May 07; 49(3):344-352. PubMed ID: 31308034
    [Abstract] [Full Text] [Related]

  • 20. Small Intestinal Bacterial Overgrowth in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Case-Control Studies.
    Shah A, Talley NJ, Jones M, Kendall BJ, Koloski N, Walker MM, Morrison M, Holtmann GJ.
    Am J Gastroenterol; 2020 Feb 07; 115(2):190-201. PubMed ID: 31913194
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.